Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.
about
High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA studyAssociation between lifestyle factors and plasma adiponectin levels in Japanese men.Exercise induced adipokine changes and the metabolic syndromeInflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysisMetabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and HepatokinesThe peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectinAdiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeCirculating cellular adhesion molecules and risk of diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).Helicobacter pylori infection and diabetes: is it a myth or fact?Obesity, inflammation, and lung injury (OILI): the good.Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study.The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin.Association between risk factors for vascular dementia and adiponectin.Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype.Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).Influence of waist on adiponectin and insulin sensitivity in adolescence.Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: a population-based epidemiological study.Circulating adiponectin levels and risk of type 2 diabetes in the Japanese.Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitusCombined use of serum adiponectin and tumor necrosis factor-alpha receptor 2 levels was comparable to 2-hour post-load glucose in diabetes prediction.Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. the CoLaus study.Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies.Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention.Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation.The complexities of obesity and diabetes with the development and progression of pancreatic cancer.Interaction between Adiponectin and Aldosterone.Smoking and diabetes: is the association mediated by adiponectin, leptin, or C-reactive protein?Evaluation of the combined use of adiponectin and C-reactive protein levels as biomarkers for predicting the deterioration in glycaemia after a median of 5.4 years.Adiponectin in cardiovascular inflammation and obesitySerum ferritin has correlation with HbA1c in type 2 diabetic patients.Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans.Hypoadiponectinemia in obese subjects with type II diabetes: A close association with central obesity indices.Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation.Variations in levels of IL-6 and TNF-α in type 2 diabetes mellitus between rural and urban Ashanti Region of Ghana.Association of hypoadiponectemia with smokeless/dipping tobacco use in young menCirculating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women.Development of associations among central adiposity, adiponectin and insulin sensitivity from adolescence to young adulthood.Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case-control study nested within the Singapore Chinese Health Study.Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus.
P2860
Q24792427-ED69F339-25A9-4020-8FD2-ADE51BD1604EQ24812059-5BE80FE9-5CB2-4765-8111-0B3003A262FDQ26822992-7EF64B71-084E-4F2E-9001-BC49CCDF69ACQ26829404-1C7E7269-4216-4293-9024-463FB4169910Q28066564-E2EE98EF-8FE6-400E-BEBA-7E4F19223ABCQ28585701-C8982A6A-96E5-4B0B-ABFC-84930F0B3868Q29619211-4F79149F-3F67-4941-BC57-88DD0DB9886AQ30277225-3D7CBB35-C8F8-491F-A160-02731E48EF26Q30361927-34AE9092-41AE-4F2B-BC72-ED0E55D6830AQ30363313-3C1D000F-90B1-4DE9-A871-84F899154193Q33509887-325B181D-EA7E-473E-B948-F1DB0D18C7B7Q33572275-0E855050-4DCB-42F2-9754-5A2C51F26A2FQ33594133-5BCFF65A-6D3D-41AC-BCF6-C1A3C599E157Q33673519-36698DEF-6D80-4783-B2A1-3CFDA6535640Q33751519-9D309D98-1409-441C-B015-0ACC84BF86D7Q33822103-4D6EFC1A-CB55-40A1-B975-70A2CDE0E891Q34088086-EA61543B-D3D6-4F05-A008-6C9701548765Q34117330-326F9CA6-2EA9-4014-BAC5-503591F8E323Q34256560-35967999-9676-42DE-A4A5-BBF7F502C163Q34277467-4CAEBA66-1D46-406F-ABD1-A931C18BCD22Q34517195-1D08CBED-29C4-443A-B9B5-D92FA729F427Q34606650-19B82E0A-03C7-4551-B432-595298660879Q34620441-9D535CD9-B299-4B62-A2B5-755F2FC6B9A4Q34620459-225557F9-78F2-4371-99AF-37C360DC6AAAQ34669361-570CAFCD-50FF-4E0D-9CCA-38EBB637DD7DQ35005352-B501B1DE-D13E-42E4-9597-76D8A31E7054Q35028163-213FAB7F-778B-447F-BBDA-B6127B9D67C6Q35201559-1A874D46-4CC6-42EB-B4EA-5C610646BC44Q35219362-6519935F-406F-4B56-BEA5-28F5F48118E8Q35277796-6F65E333-C4AB-4BEA-82F4-73A9400D1F44Q35304374-F205E4B7-57A8-49FA-B424-08768D0D16A2Q35544900-6D690A13-8B21-48D7-A540-8862F602B031Q35658773-AFF9A79D-82CE-4CCE-8D8D-4CD942E1F76EQ35782503-DBA31E2A-4564-49F9-8BD4-AA1FE99FF8EDQ35813776-81CF1F0F-D5F7-4D30-98FD-D6C88CBD9721Q35950454-588F72D6-B440-4B5E-BB3E-D178792D361FQ36162001-D7765369-5E88-4E92-B603-116C5BD9FC00Q36236500-6BC87FCD-B514-4B13-9C36-CC59F9BBC6F0Q36274586-A7311060-18F9-40F4-A749-DCFC5F062BD7Q36285571-B7F5BB78-9639-4A21-970A-98BF42C49DE2
P2860
Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.
@en
Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.
@nl
type
label
Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.
@en
Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.
@nl
prefLabel
Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.
@en
Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.
@nl
P2093
P50
P1433
P1476
Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian
@en
P2093
Jonathan Krakoff
P Antonio Tataranni
Sachiyo Tanaka
Sayuko Kobes
Tohru Funahashi
Yuji Matsuzawa
P304
P356
10.2337/DIACARE.26.6.1745
P407
P50
P577
2003-06-01T00:00:00Z